2,105
Views
2
CrossRef citations to date
0
Altmetric
Articles

On-the-road driving performance of patients with central disorders of hypersomnolence

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 120-126 | Received 13 Feb 2020, Accepted 07 Dec 2020, Published online: 05 Feb 2021

References

  • Åkerstedt T, Gillberg M. 1990. Subjective and objective sleepiness in the active individual. Int J Neurosci. 52(1-2):29–37. doi:10.3109/00207459008994241
  • Althunian TA, de Boer A, Groenwold RH, Klungel OH. 2017. Defining the noninferiority margin and analysing noninferiority: an overview. Br J Clin Pharmacol. 83(8):1636–1642. doi:10.1111/bcp.13280
  • American Academy of Sleep Medicine. 2014. International classification of sleep disorders—third edition (ICSD-3). AASM Resource Library [online].
  • Bakhtiari R, Tomczak MV, Langor S, Scanlon JE, Granley A, Singhal A. 2020. Application of tablet-based cognitive tasks to predict unsafe drivers in older adults. Transp Res Interdiscip Perspect. 4:100105. doi:10.1016/j.trip.2020.100105
  • Blomberg RD, Peck RC, Moskowitz H, Burns M, Fiorentino D. 2009. The long beach/fort lauderdale relative risk study. J Saf Res. 40(4):285–292. doi:10.1016/j.jsr.2009.07.002
  • Borkenstein RF, Crowther R, Shumate R. 1974. The role of the drinking driver in traffic accidents (The Grand Rapids Study). Blutalkohol. 11:1–131.
  • Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding C, Lecomte J, Schwartz J. 2013. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 12(11):1068–1075. doi:10.1016/S1474-4422(13)70225-4
  • Faul F, Erdfelder E, Lang A-G, Buchner A. 2007. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 39(2):175–191. doi:10.3758/bf03193146
  • Findley LJ, Suratt PM, Dinges DF. 1999. Time-on-task decrements in “steer clear” performance of patients with sleep apnea and narcolepsy. Sleep. 22(6):804–809. doi:10.1093/sleep/22.6.804
  • George C, Boudreau A, Smiley A. 1996. Comparison of simulated driving performance in narcolepsy and sleep apnea patients. Sleep. 19(9):711–717. doi:10.1093/sleep/19.9.711
  • Higgins JS, Michael J, Austin R, Åkerstedt T, Van Dongen HP, Watson N, Czeisler C, Pack AI, Rosekind MR. 2017. Asleep at the wheel—the road to addressing drowsy driving. Sleep. 40(2):zsx001. doi:10.1093/sleep/zsx001
  • Jongen S, Perrier J, Vuurman EFPM, Ramaekers JG, Vermeeren A. 2015. Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivation. PloS One. 10(2):e0117045. doi:10.1371/journal.pone.0117045
  • Jongen S, Vermeeren A, van der Sluiszen N, Schumacher MB, Theunissen EL, Kuypers KPC, Vuurman EFPM, Ramaekers JG. 2017. A pooled analysis of on-the-road highway driving studies in actual traffic measuring standard deviation of lateral position (i.e., "weaving") while driving at a blood alcohol concentration of 0.5 g/L). Psychopharmacology (Berl). 234(5):837–844. doi:10.1007/s00213-016-4519-z
  • Kornum BR, Knudsen S, Ollila HM, Pizza F, Jennum PJ, Dauvilliers Y, Overeem S. 2017. Narcolepsy. Nat Rev Dis Primers. 3:16100. doi:10.1038/nrdp.2016.100
  • Kotterba S, Mueller N, Leidag M, Widdig W, Rasche K, Malin J-P, Schultze-Werninghaus G, Orth M. 2004. Comparison of driving simulator performance and neuropsychological testing in narcolepsy. Clin Neurol Neurosurg. 106(4):275–279. doi:10.1016/j.clineuro.2003.12.003
  • Kotterba S, Müller N, Steiner G, Mayer G. 2002. Fahrverhalten bei Narkolepsie–Fragebogenanalyse unter Betroffenen: driving in narcolepsy–analysis by questionnaire among patients. Somnologie. 6:26–33.
  • Littner MR, Kushida C, Wise M, Davila G, Morgenthaler T, Lee-Chiong T, Hirshkowitz M, Loube DL, Bailey D, Berry RB, et al. 2005. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 28(1):113–121. doi:10.1093/sleep/28.1.113
  • Louwerens JW, Gloerich ABM, DeVries G, Brookhuis KA, O’Hanlon JF. 1987. The relationship between drivers’ blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC, Roszbach R, editors. Alcohol Drugs Traffic Safety - T86. Amsterdam: Elsevier. p. 183–186.
  • Michon JA. 1989. Explanatory pitfalls and rule-based driver models. Accid Anal Prev. 21(4):341–353. doi:10.1016/0001-4575(89)90025-0
  • O’Hanlon JF. 1984. Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol. 18(S1):121S–129S. doi:10.1111/j.1365-2125.1984.tb02590.x
  • Philip P, Chaufton C, Taillard J, Capelli A, Coste O, Leger D, Moore N, Sagaspe P. 2014. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial. Sleep. 37(3):483–487. doi:10.5665/sleep.3480
  • Philip P, Chaufton C, Taillard J, Sagaspe P, Leger D, Raimondi M, Vakulin A, Capelli A. 2013. Maintenance of Wakefulness Test scores and driving performance in sleep disorder patients and controls. Int J Psychophysiol. 89(2):195–202. doi:10.1016/j.ijpsycho.2013.05.013
  • Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, CONSORT Group. 2012. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 308(24):2594–2604. doi:10.1001/jama.2012.87802
  • Piersma D, Fuermaier AB, de Waard D, Davidse RJ, de Groot J, Doumen MJ, Bredewoud RA, Claesen R, Lemstra AW, Vermeeren A, et al. 2016. Prediction of fitness to drive in patients with Alzheimer's dementia. PLoS One. 11(2):e0149566. doi:10.1371/journal.pone.0149566
  • Pizza F, Jaussent I, Lopez R, Pesenti C, Plazzi G, Drouot X, Leu-Semenescu S, Beziat S, Arnulf I, Dauvilliers Y. 2015. Car crashes and central disorders of hypersomnolence: a French study. PloS One. 10(6):e0129386. doi:10.1371/journal.pone.0129386
  • Ramaekers JG. 2017. Drugs and driving research in medicinal drug development. Trends Pharmacol Sci. 38(4):319–321. doi:10.1016/j.tips.2017.01.006
  • Ramaekers JG, Conen S, de Kam PJ, Braat S, Peeters P, Theunissen EL, Ivgy-May N. 2011. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype. Psychopharmacology (Berl). 215(2):321–332. doi:10.1007/s00213-010-2149-4
  • Sagberg F, Jackson P, Krüger H-P, Muzet A, Williams A. 2004. Fatigue, sleepiness and reduced alertness as risk factors in driving (TØI report 739/2004). Oslo, Norway: Institute of Transport Economics Oslo.
  • Van der Sluiszen N, Vermeeren A, Verster J, van de Loo AJAE, van Dijken J, Veldstra J, Brookhuis KA, de Waard D, Ramaekers JG. 2019. Driving performance and neurocognitive skills of long‐term users of benzodiazepine anxiolytics and hypnotics. Hum Psychopharmacol Clin Exp. 34(6):e2715. doi:10.1002/hup.2715
  • Van Schie MKM, Werth E, Lammers GJ, Overeem S, Baumann CR, Fronczek R. 2016. Improved vigilance after sodium oxybate treatment in narcolepsy: a comparison between in‐field and in‐laboratory measurements. J Sleep Res. 25(4):486–496. doi:10.1111/jsr.12386
  • Vermeeren A. 2004. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 18(5):297–328. doi:10.2165/00023210-200418050-00003
  • Verster JC, Roth T. 2012. Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills. Psychopharmacology (Berl). 220(2):293–301. doi:10.1007/s00213-011-2484-0